CECT IN THE ADRENOCORTICAL CARCINOMAS: RECOGNIZING THE TYPICAL MORPHOLOGICAL FEATURES

KRITIKAL; RAJARAM SHARMA; SAMBHAV LODHA; HEMANGINI THAKKAR; PADMA BADHE

doi:10.22159/ajpcr.2023.v16i2.47219

Authors

KRITIKAL Department of , Pacific Institute of Medical Sciences, Udaipur, Rajasthan, India.
RAJARAM SHARMA Department of , Pacific Institute of Medical Sciences, Udaipur, Rajasthan, India.
SAMBHAV LODHA Department of , Geetanjali Medical College and Hospital, Udaipur, Rajasthan, India.
HEMANGINI THAKKAR Department of , SGMC Medical College, KEM Hospital, Mumbai, Maharashtra, India.
PADMA BADHE Department of , SGMC Medical College, KEM Hospital, Mumbai, Maharashtra, India.

DOI:

https://doi.org/10.22159/ajpcr.2023.v16i2.47219

Keywords:

Adrenal, Contrast-enhanced computed tomography, Washout, Carcinoma

Abstract

Objectives: This study was characterization of adrenal masses on computer tomography (CT) using shape, size, and enhancement patterns.

Methods: It is a retrospective study of 86 adrenal masses with morphological differences in the appearance and enhancement patterns (histopathologically proven 36 pheochromocytoma [PCCs], 26 adrenal cortical carcinoma [ACCs], one lymphoma, 22 metastases, and one schwannoma). Two experienced radiologists who were unaware of the histopathological diagnosis reviewed the computed tomography scans, morphological parameters had been noted, along with attenuations measured in Hounsfield units for all the phases of contrast-enhanced computed tomography.

Results: Necrosis had been seen in all the cases of ACCs with a loss of adeniform shape. ACCs were significantly less enhancing in arterial phase and venous phase than PCC; however, no significant difference was seen with lymphomas, metastasis, and schwannoma. 25/33 (75.5%) ACC showed heterogeneous enhancement (due to the presence of necrosis) in the VP.

Conclusion: Heterogenous architecture with a size of more than 5 cm is relatively specific for diagnosing ACC. No specific enhancement pattern could well differentiate ACC from lymphoma, metastases, and schwannoma.

Downloads

Download data is not yet available.

References

Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: Update in diagnosis and management. Endocr Rev 2004;25:309-40. doi: 10.1210/er.2002-0031, PMID 15082524

Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, et al. Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol 2016;175:G1-34. doi: 10.1530/EJE-16-0467, PMID 27390021

Szolar DH, Kammerhuber FH. Adrenal adenomas and non-adenomas: Assessment of washout at delayed contrast-enhanced CT. Radiology 1998;207:369-75. doi: 10.1148/radiology.207.2.9577483, PMID 9577483

Blake MA, Kalra MK, Sweeney AT, Lucey BC, Maher MM, Sahani DV, et al. Distinguishing benign from malignant adrenal masses: Multi-detector-row CT protocol with 10-minute delay. Radiology 2006;238:578-85. doi: 10.1148/radiol.2382041514, PMID 16371582

Park BK, Kim CK, Kim B, Lee JH. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 2007;243:760-5. doi: 10.1148/ radiol.2433051978, PMID 17517932

Caoili EM, Korobkin M, Francis IR, Cohan RH, Platt JF, Dunnick NR, et al. Adrenal masses: Characterization with combined unenhanced and delayed enhanced CT. Radiology 2002;222:629-33. doi: 10.1148/ radiol.2223010766, PMID 11867777

Szolar DH, Korobkin M, Reittner P, Berghold A, Bauernhofer T, Trummer H, et al. Adrenocortical carcinomas and adrenal pheochromocytomas: Mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 2005;234:479-85. doi: 10.1148/ radiol.2342031876, PMID 15671003

Boland GW, Hahn PF, Peña C, Mueller PR. Adrenal masses: Characterization with delayed contrast-enhanced CT. Radiology 1997;202:693-6. doi: 10.1148/radiology.202.3.9051018, PMID 9051018

Shrimpton P. Assessment of patient dose in CT. In: EUR. European Guidelines for Multislice Computed Tomography Funded by the European Commission 2004: Contract Number FIGMCT2000-20078- CT-TIP. Luxembourg: European Commission; 2004.

Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR. Londy F. CT time-attenuation washout curves of adrenal adenomas and non-adenomas. AJR Am J Roentgenol 1998;170:747-52.

O’Connor JP, Tofts PS, Miles KA, Parkes LM, Thompson G, Jackson A. Dynamic contrast-enhanced imaging techniques: CT and MRI. Br J Radiol 2011;84:S112-20. doi: 10.1259/bjr/55166688, PMID 22433822

Favier J, Gimenez-Roqueplo AP. Pheochromocytomas: The (pseudo)-hypoxia hypothesis. Best Pract Res Clin Endocrinol Metab 2010;24:957-68. doi: 10.1016/j.beem.2010.10.004, PMID 21115164

Zhang YM, Lei PF, Chen MN, Lv XF, Ling YH, Cai PQ, et al. CT findings of adrenal schwannoma. Clin Radiol 2016;71:464-70. doi: 10.1016/j.crad.2016.01.010, PMID 26897337

Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT: Prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 2008;190:1163-8. doi: 10.2214/AJR.07.2799, PMID 18430826